DaVita Inc

Most Recent

  • Energy & Utilities

    Buffett’s Berkshire Hathaway opens a position in Liberty Global

    International cable company Liberty Global (LBTYA) is a new 0.25% position initiated by Berkshire Hathaway in 4Q. Liberty Global operates in 14 countries, including 12 European countries.

    By Samantha Nielson
  • uploads///Graph
    Miscellaneous

    Which Hospital Stocks Are Expected to Benefit Most?

    Trumpcare’s failure is considered to be a boon by hospital companies treating a significant portion of Medicaid members.

    By Margaret Patrick
  • uploads///DVA
    Fund Managers

    DaVita HealthCare Partners is New Stake in Lone Pine’s Portfolio

    DaVita posted 4Q14 net earnings of $208 million, or $0.96 per share, compared with $212.3 million, or $0.99 per share, last year.

    By Samantha Nielson
  • uploads///LBTYK
    Consumer

    Warren Buffett’s Berkshire Hathaway ups its Liberty Global stake

    Berkshire Hathaway added to its position in Liberty Global PLC (LBTYK) last quarter. The position now accounts for 0.57% of Berkshire’s 1Q 2014 portfolio, up from 0.25% last quarter.

    By Samantha Nielson
  • uploads///DVA
    Consumer

    Lone Pine Capital starts new positions in BIDU, MA, DVA, P, Sells ISRG, RL – 13F Flash (C)

    Lone Pine Capital LLC, based in Greenwich, Connecticut, was founded in 1997 by Stephen Mandel and is one of the largest equity-focused hedge funds in the United States. It is estimated to have $28.3 billion of assets under management. In Q3 2013, it started new positions in Baidu Inc. (BIDU), MasterCard Inc. (MA), Davita Healthcare […]

    By Samantha Nielson
  • uploads///MA
    Consumer

    Lone Pine Capital starts new positions in BIDU, MA, DVA, P, Sells ISRG, RL – 13F Flash (B)

      Lone Pine Capital LLC, based in Greenwich, Connecticut, was founded in 1997 by Stephen Mandel and is one of the largest equity-focused hedge funds in the United States. It is estimated to have $28.3 billion of assets under management. In Q3 2013, it started new positions in Baidu Inc. (BIDU), MasterCard Inc. (MA), Davita […]

    By Samantha Nielson
  • Consumer

    Berkshire Hathaway buys a new stake in Verizon Communications

    Berkshire Hathaway took a new position in Verizon Communications (VZ) last quarter. The position accounts for 2.04% of the fund’s portfolio.

    By Samantha Nielson
  • uploads///Chart
    Company & Industry Overviews

    Estimates and Recommendations for DaVita on September 17

    Analysts estimate that DaVita (DVA) will report a 25.3% decline in revenues to $11.6 billion in 2018 compared to $15.5 billion in 2017.

    By Mike Benson
  • uploads///medic _
    Company & Industry Overviews

    DaVita’s Valuation on September 17

    DaVita currently trades at a forward PE multiple of 15.2x compared to the industry average of 15.1x as of September 17.

    By Mike Benson
  • uploads///Graph
    Company & Industry Overviews

    Fresenius Medical Care Is a Global Leader in the Dialysis Segment

    In addition to selling dialysis products, Fresenius Medical Care also offers dialysis treatment and associated laboratory services to patients through its network of 3,690 clinics.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    EMEA and APAC: Fresenius Medical Care’s Dialysis Products Business

    In 1H17, Fresenius Medical Care (FMS) earned ~1.6 billion euros from the sale of dialysis products, which equals year-over-year growth of 8% on a reported basis.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    North America: Fresenius Medical Care’s Major Target Market in 2017

    In 2Q17, Fresenius Medical Care (FMS) reported revenues close to 3.3 billion euros, which represents year-over-year growth of ~11%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Fresenius Medical Care’s Net Profit Margins Could Fall Slightly

    For fiscal 2017, Wall Street analysts have projected Fresenius Medical Care’s net profit margins to be close to 6.2%, which is a YoY decline of ~70 basis points.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    How Analysts View Fresenius Medical Care and Its Peers in August 2017

    In 1H17, Fresenius Medical Care (FMS) reported revenues close to 9.0 billion euros, which represents 14% YoY growth. At the end of 2Q17, the company operated 3,690 dialysis clinics around the world.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Quest Diagnostics’ Multi-Pronged Strategy to Accelerate Growth

    Quest Diagnostics (DGX) expects to witness a 3.0%–5.0% long-term revenue growth rate in the future with earnings growth of 5.0%–9.0%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Quest Diagnostics Is Targeting 3 Focus Areas to Accelerate Growth

    Since 2012, Quest Diagnostics (DGX) has spent about $1.0 billion on capital investments and $1.0 billion on ten acquisitions to support inorganic growth.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Quest Diagnostics Is Making Steady Progress in 5-Point Strategy

    Since 2012, Quest Diagnostics (DGX) has been working on a five-point strategy to boost revenue growth and improve quality, service, and efficiency.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Quest Diagnostics Projects Run Rate Savings by End of 2017

    Quest Diagnostics (DGX) has projected a run rate savings worth $1.3 billion by the end of 2017. In 2016, it managed to save up to $1.1 billion.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Quest Diagnostics’ Reference Testing, Hospital Outreach Segment

    With services offered to about half of the total hospitals, Quest Diagnostics (DGX) has become a leading provider of reference testing services in the United States.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Quest Diagnostics Could Get Greater Share of Laboratory Segment

    With around 50.0% of hospitals being served by Quest Diagnostics (DGX), the company has become a leading player in the fragmented US laboratory market.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    LabCorp Trades at Discounted PE Multiples Compared with Peers in 1Q16

    In a survey of 22 brokerage companies on April 26, 2016, about 71.4% of the brokers rated LabCorp (LH) a “buy,” while 28.6% rated it a “hold.” None of the brokers rated it a “sell.”

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    LabCorp’s Growth Drivers in 1Q16: Organic Growth, Acquisitions

    In 1Q16, LabCorp’s (LH) national clinical laboratory business, LabCorp Diagnostics, accounted for 69.3% of the company’s total revenues.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Understanding Quest Diagnostics’ Valuation Multiple Compared to Those of Peers

    Quest Diagnostics trades at a premium multiple compared to Lab Corp of America and at a big discount compared to peers Davita Healthcare and IDEXX Labs.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Revenue Growth Initiatives Drove LabCorp’s Performance in 1Q16

    In 1Q16, LabCorp (LH) reported strong revenue and earnings growth due to the effective implementation of multiple strategic initiatives. LabCorp is the world’s leading healthcare diagnostics company.

    By Margaret Patrick
  • uploads///Part  Graph
    Company & Industry Overviews

    DaVita’s Stock Reacts to the Merger with The Everett Clinic

    DaVita HealthCare Partners (DVA) was one of the biggest winners for the week ending March 4 with a return of 6.1%.

    By Peter Neil
  • uploads///Graph
    Company & Industry Overviews

    Changes in Behavioral Health Business May Boost UHS’s Valuations

    Universal Health Services’ behavioral health revenues rose by 9.7%, from $4 billion in 2014 to $4.4 billion in 2015.

    By Margaret Patrick
  • Healthcare

    Why-high-yield issuers coast on “drive-by” and “add-on” deals

    DaVita HealthCare Partners (DVA) and Tenet Healthcare (THC) were among the more prominent HY debt issuers in the week ending June 13.

    By Phalguni Soni
  • uploads///GSH
    Energy & Utilities

    Berkshire Hathaway reveals a new position in Goldman Sachs

    Berkshire Hathaway opened a brand new position in Goldman Sachs that accounts for 2.14% of the investment company’s $104 billion portfolio.

    By Samantha Nielson
  • uploads///pricing e
    Healthcare

    Medtronic purchases Cardiocom: Bad for medical device industry?

    Medtronic has always been considered a bellwether for the medical device industry because of its pure focus on the device market. Yet that changed in mid-August, as Medtronic announced its acquisition of Cardiocom.

    By Amritpal Khalsa
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.